Replication of the Scandinavian Simvastatin Survival Study using a primary care medical record database prompted exploration of a new method to address unmeasured confounding

Pharmacoepidemiology and Drug Safety

Volumn 17, Issue 7, 2008, Pages 661-670

  Weiner, Mark G ^a   Xie, Dawei ^a   Tannen, Richard L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bias (epidemiology); Cohort studies; Medical record database; Randomized controlled trials; Statins; Statistics

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; NITRATE; SIMVASTATIN;

ANALYTIC METHOD; ARTICLE; CLINICAL RESEARCH; DATA ANALYSIS; DATA BASE; ELECTRONIC MEDICAL RECORD; GENERAL PRACTICE RESEARCH DATABASE; HAZARD RATIO; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERCHOLESTEROLEMIA; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; METHODOLOGY; OBSERVATIONAL STUDY; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REPLICATION STUDY; UNITED KINGDOM; VALIDITY;

ADULT; AGED; CONFOUNDING FACTORS (EPIDEMIOLOGY); CORONARY DISEASE; DATA INTERPRETATION, STATISTICAL; DATABASES, FACTUAL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SIMVASTATIN; SURVIVAL ANALYSIS;

EID: 48249156614     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1585     Document Type: Article

References (14)

1. Tannen RL, Weiner MG, Marcus SM. Simulation of the Syst-Eur randomized control trial using a primary care electronic medical record was feasible. J. Clin. Epidemiol. 2006; 59: 254-264.
2. Tannen RL, Weiner MG, Xie D, Barnhart K. A simulation using data from a primary care practice database closely replicated the Women's Health Initiative Trial. J. Clin. Epidemiol. 2007; 60: 686-695.
3. Tannen RL, Weiner MG, Xie D, Barnhart K. Estrogen affects post-menopausal women differently than estrogen plus progestin replacement therapy. J. Hum. Reprod. 2007; 22: 1769-1777.
4. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
5. Wilt TJ, Bloomfield HE, MacDonald R, Nelson D, Rutks I, et al. Effectiveness of statin therapy in adults with coronary heart disease. Arch. Intern. Med. 2004; 164: 1427-1436.
6. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1276-1278.
7. Costa J, Borges M, David C, Carneiro AV. Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomized controlled trials. Br. Med. J. 2006; 332: 1115-1124.
8. Gelfand JM, Margolis DJ, Dattani H. The UK General Practice Research Data Base. In Strom BL (ed). Pharmacoepidemiology (4th edn), John Wiley and Sons: New York, 2005; 337-346.
9. Raghunathan TE, Solenberger PW, Van Hoewyk J. IVEware: Imputation and Variance Estimation Software. Institute for Social Research, University of Michigan, Ann Arbor, MI, 1998.
10. Rubin D. Multiple Imputation for Non-response in Surveys. John Wiley and Sons, Inc: New York, NY, 1987.
11. Raghunathan TE, Lepkowski JM, Van Hoewyk J, Solenberger PW. A multivariate technique for multiply imputing missing values using a sequence of regression models. Surv. Methodol. 2001; 27: 85-95.
12. Rosenbaum P, Rubin D. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70: 41-55.
13. Rosenbaum P, Rubin D. Reducing bias in observational studies using subclassification on the propensity score. J. Am. Stat. Assoc. 1984; 79: 516-524.
14. D'Agostino RB, Rubin DB. Estimating and using propensity scores with partially missing data. J. Am. Stat. Assoc. 2000; 95: 749-759.